...
首页> 外文期刊>Thoracic cancer. >Expression and role of p16 and GLUT1 in malignant diseases and lung cancer: A review
【24h】

Expression and role of p16 and GLUT1 in malignant diseases and lung cancer: A review

机译:P16和Glut1在恶性疾病和肺癌中的表达及作用:综述

获取原文

摘要

Non-small cell lung cancer (NSCLC) is the leading cause of cancer death and in most cases it is often diagnosed at an advanced stage. Many genetic and microenvironmental factors are able to modify the cell cycle inducing carcinogenesis and tumor growth. Among the metabolic and genetic factors that come into play in carcinogenesis and tumor cell differentiation and growth there are two different proteins that should be considered which are glucose transporters (GLUTs) and p16 INK4 The first are glucose transporters which are strongly involved in tumor metabolism, notably accelerating cancer cell metabolism both in aerobic and anaerobic conditions. There are different subtypes of GLUT family factors of which GLUT 1 is the most important and widely expressed. By contrast, p16 is mainly a tumor-suppressor protein that acts on cyclin-dependent kinase favoring cell cycle arrest in the G1 phase. Our search focused on the action of the aforementioned factors.? 2020 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd.
机译:非小细胞肺癌(NSCLC)是癌症死亡的主要原因,并且在大多数情况下,它通常在高级阶段被诊断出来。许多遗传和微环境因素能够改变细胞周期诱导致癌致癌和肿瘤生长。在致癌物和肿瘤细胞分化和生长中发挥的代谢和遗传因素存在两种不同的蛋白质,应该考虑是葡萄糖转运蛋白(凝乳)和P16 Ink4首先是葡萄糖转运蛋白,其强烈地参与肿瘤代谢,在有氧和厌氧条件下,显着加速癌细胞代谢。有不同的污水家庭因素亚型,其中一个完全是最重要和广泛表达的。相比之下,P16主要是肿瘤抑制蛋白,其作用于在G1相中有利于细胞周期停滞的细胞周期依赖性激酶。我们的搜索侧重于上述因素的行动。 2020作者。中国肺部肿瘤集团和约翰瓦里和儿子澳大利亚发表的胸癌

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号